Graham Capital Management, L.P.
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1315421
ROWAYTON, CT
Position in PBH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$337,318
-$59,850 QoQ
Shares Held
7,136
+6.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. PBH ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
75,653 | $1,212,717 | |
| 2 | HLN |
Haleon plc
|
55,057 | $513,681 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
101,971 | $502,717 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,035 | $416,045 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
7,136 | $337,318 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
8,555 | $309,691 | |
| 7 | ZTS |
Zoetis Inc.
|
4,304 | $309,285 | |
| 8 | PRGO |
PERRIGO Co plc
|
28,290 | $293,933 |
All Filings in PBH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,318 | 7,136 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $397,168 | 6,701 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $443,797 | 7,194 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $460,886 | 7,386 | Shares | Sole | 2025-11-14 | |
| 2023-06-30 | $705,731 | 11,875 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $1,674,492 | 31,630 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||